<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03248076</url>
  </required_header>
  <id_info>
    <org_study_id>Opioids-OPU</org_study_id>
    <nct_id>NCT03248076</nct_id>
  </id_info>
  <brief_title>Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.</brief_title>
  <official_title>Effect of Fentanyl on Expression of Main Opioid Receptor (OPRM1) on Human Granulosa Cells During Ultrasound-guided Transvaginal Oocyte Retrieval.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Papanicolaou Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Papanikolaou Evaggelos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Naidecki Robert</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pakaki Fay</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Raikos Nikolaos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>George Papanicolaou Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioids is known that produce not only analgesia but also hyperalgesia through activation of
      central glutaminergic system-GABA. At the same time, recently it was found that the main
      opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their
      antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production
      via OPRM1, causing ovarian hyperstimulation syndrome.

      This study aims to investigate if a single exposure to opioids is enough to produce
      activation of stress mechanism during oocyte retrieval.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates
      and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF)
      production via OPRM1, causing ovarian hyperstimulation syndrome.

      This study aims to investigate if a single exposure to opioids is enough to produce
      activation of stress mechanism during ultrasound-guided oocyte retrieval. It will be measured
      the level of cortisone before and 15min after iv administration of fentanyl on blood and on
      oocyte fluid.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">October 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fentanyl</measure>
    <time_frame>15 minutes</time_frame>
    <description>fentanyl on blood sample and oocyte fluid</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cortisone</measure>
    <time_frame>15 min</time_frame>
    <description>cortisone on blood sample and oocyte fluid</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stress Reaction</condition>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Fentanyl citrate</arm_group_label>
    <description>Baseline blood sample and oocyte fluid will be collected under propofol anesthesia. Fifteen minutes after administration of 1γ/kgfentanyl, it will be collected again blood sample and oocyte fluid. Cortisone and fentanyl level will be measured in all samples.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate</intervention_name>
    <description>1γ/Kg fentanyl</description>
    <arm_group_label>Fentanyl citrate</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers oocyte donor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Physical Status I-III, BMI&lt;30,

        Exclusion Criteria:

          -  Heart failure

          -  hepatic failure, hepatitis,

          -  drug abuse

          -  receiving b blockers

          -  receiving b agonists (even bronchodilators)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>32 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Asouhidou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assisting Nature</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irene Asouhidou, MD, PhD</last_name>
    <phone>00302310999321</phone>
    <email>iasouh@aol.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evaggelos Papanikolaou, MD, PhD</last_name>
    <phone>00302310424294</phone>
    <email>drvagpapanikolaou@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Section of Anatomy, Aristotle University of Thessaloniki</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54124</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Asouhidou, MD, PhD</last_name>
      <phone>2310999321</phone>
      <email>iasouh@aol.com</email>
    </contact>
    <contact_backup>
      <last_name>Evaggelos Papanikolaou, MD, PhD</last_name>
      <phone>+302310424294</phone>
      <email>drvagpapanikolaou@yahoo.gr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Böttcher B, Seeber B, Leyendecker G, Wildt L. Impact of the opioid system on the reproductive axis. Fertil Steril. 2017 Aug;108(2):207-213. doi: 10.1016/j.fertnstert.2017.06.009. Epub 2017 Jun 29. Review.</citation>
    <PMID>28669481</PMID>
  </reference>
  <reference>
    <citation>Lunger F, Vehmas AP, Fürnrohr BG, Sopper S, Wildt L, Seeber B. Opiate receptor blockade on human granulosa cells inhibits VEGF release. Reprod Biomed Online. 2016 Mar;32(3):316-22. doi: 10.1016/j.rbmo.2015.12.006. Epub 2016 Jan 6.</citation>
    <PMID>26803207</PMID>
  </reference>
  <reference>
    <citation>Kouvaras E, Asprodini EK, Asouchidou I, Vasilaki A, Kilindris T, Michaloudis D, Koukoutianou I, Papatheodoropoulos C, Kostopoulos G. Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug. Neuropharmacology. 2008 Dec;55(7):1172-82. doi: 10.1016/j.neuropharm.2008.07.025. Epub 2008 Jul 26.</citation>
    <PMID>18706433</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2017</study_first_submitted>
  <study_first_submitted_qc>August 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Papanicolaou Hospital</investigator_affiliation>
    <investigator_full_name>Asouhidou Irene</investigator_full_name>
    <investigator_title>Assisting Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Stress</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

